---
title: "600267.SH (600267.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/600267.SH/news.md"
symbol: "600267.SH"
name: "600267.SH"
parent: "https://longbridge.com/en/quote/600267.SH.md"
datetime: "2026-05-21T02:55:50.764Z"
locales:
  - [en](https://longbridge.com/en/quote/600267.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/600267.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/600267.SH/news.md)
---

# 600267.SH (600267.SH) — Related News

### [HISUN Animal Health Strategic Layout: How to Break Through the Pet Medicine Market Without Being the "Low-Price King"?](https://longbridge.com/en/news/286098346.md)
*2026-05-12T12:09:11.000Z*
> HISUN Animal Health expects that by 2025, the pet business will account for over 55%, with e-commerce sales growth reach

### [As anti-aging star ingredients move towards standardization, how can LianSheng Synthetic seize the opportunity in the billion-dollar market of ergothioneine?](https://longbridge.com/en/news/286071073.md)
*2026-05-12T09:28:10.000Z*
> With the acceleration of the standardization process of the anti-aging ingredient ergothioneine, Yunsheng Synthesis, lev

### [Directly hitting the Expo: Breaking through the facade of prosperity, HISUN's "entry" and "breakthrough"](https://longbridge.com/en/news/285844311.md)
*2026-05-10T14:17:18.000Z*
> HISUN Animal Health showcased its business development at the 6th TOPS Expo in 2026, expecting to achieve operating reve

### [HISUN's net profit in Q1 increased by 83%. How did HISUN achieve this?](https://longbridge.com/en/news/284424076.md)
*2026-04-28T15:26:54.000Z*
> HISUN achieved a net profit of 356 million yuan in the first quarter of 2026, a year-on-year increase of 83.13%. Operati

### [Haina Pharmaceutical faces a critical battle in the Hong Kong stock market with a 400 million bet, as orders decrease, performance declines, and cash remaining is only 63 million](https://longbridge.com/en/news/284158205.md)
*2026-04-27T05:47:20.000Z*
> Haina Pharmaceutical (core stock) is facing a critical moment for its Hong Kong IPO, having attempted to go public three

### [HISUN, starting with a light load](https://longbridge.com/en/news/283009689.md)
*2026-04-16T12:53:41.000Z*
> HISUN reported in its 2025 annual report that revenue reached 10.55 billion yuan, a year-on-year increase of 2%, with a 

### [HISUN's net profit attributable to the parent company in the first quarter was 356 million yuan, a year-on-year increase of 83.13%](https://longbridge.com/en/news/282814287.md)
*2026-04-15T09:11:59.000Z*
> HISUN released its performance report for the first quarter of 2026, with a net profit attributable to the parent compan

### [The Shanghai Composite Index rose slightly by 0.01%, marking four consecutive gains, with the pharmaceutical sector leading the increase](https://longbridge.com/en/news/282801372.md)
*2026-04-15T07:08:00.000Z*
> The Shanghai Composite Index rose slightly by 0.01%, achieving a four-day winning streak, closing at 4027.21 points. The